721P Ipilimumab and nivolumab compassionate use program in metastatic renal cell carcinoma patients with intermediate or poor IMDC risk score: The large multicenter Italian study. - Basso, U.; Paolieri, F.; Porta, C.G.; De Giorgi, U.; Bracarda, S.; Antonuzzo, L.; Atzori, F.; Cartenì, G.; Procopio, G.; Fratino, L.; D'Arcangelo, M.; Fornarini, G.; et al. (Annals of Oncology, 2020)